Clinical Trials Logo

Clinical Trial Summary

There are limited data about the role of regulatory B cells in Behcet Disease. In this study we aimed to identify the proportions of total B lymphocytes and their regulatory subset in different Behcet Disease phenotype and therapies concentrating on the cardiovascular system attempting to unravel their function in Behcet Disease.


Clinical Trial Description

Behçet's disease is a chronic multi-organ vasculitis characterized by recurrent oral and genital aphthae, skin lesions, widespread thrombosis and aneurysmal formation, and serious involvement of the eyes and central nervous system.

The innate and adaptive immune cells integrate in the pathogenesis of Behçet's disease. Interestingly, the gene expression analysis of Behçet's disease patients and healthy controls revealed the modulation of a range of genes involved in biological processes in Behçet's disease such as inflammation, apoptosis, angiogenesis, blood coagulation, vascular damage, signalling pathways, and immune responses, particularly, in innate immune cells, Th17 cells and B cells. Yet, the regulatory role of B cells in Behçet's disease has not been thoroughly investigated. Therefore, the aim of the current study is to identify the proportions of total B lymphocytes and their regulatory subset in different Behçet's disease phenotypes and therapies attempting to unravel their function in Behcet Disease. The role of B cells and regulatory B cells in the cardiovascular system affection in Behcet Disease was studied in more details. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04376411
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date December 15, 2018
Completion date December 15, 2019

See also
  Status Clinical Trial Phase
Completed NCT00995709 - Phase III Study in Refractory Behcet's Disease Phase 3
Completed NCT02756650 - 1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement Phase 2
Recruiting NCT05904301 - Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Enrolling by invitation NCT04402255 - Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. N/A
Completed NCT02505568 - A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Phase 3
Not yet recruiting NCT04186559 - Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers Phase 2
Recruiting NCT04402086 - Rheumatology Patient Registry and Biorepository
Completed NCT00483184 - Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease Phase 2
Enrolling by invitation NCT04403438 - Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic